Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

LEVOLEUCOVORIN CALCIUM

LEVOLEUCOVORIN CALCIUM

Standard Dose
EQ 175MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LEVOLEUCOVORIN CALCIUM is listed in Drugs@FDA under application 208723 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOLEUCOVORIN CALCIUM Form and strength POWDER;INTRAVENOUS - EQ 175MG BASE/VIAL Sponsor ACTAVIS LLC Submission history Latest submission status date: 2017-03-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOLEUCOVORIN CALCIUM is listed in Drugs@FDA under application 208723 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOLEUCOVORIN CALCIUM Form and strength POWDER;INTRAVENOUS - EQ 175MG BASE/VIAL Sponsor ACTAVIS LLC Submission history Latest submission status date: 2017-03-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.